Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 36, Issue 15, Pages -Publisher
AMER SOC CLINICAL ONCOLOGY
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission
Iman Abou Dalle, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver, Xuemei Wang, Elias Jabbour, Zeev Estrov, Courtney D. DiNardo, Naveen Pemmaraju, Alessandra Ferrajoli, Nitin Jain, Sa A. Wang, Nadya Jammal, Gautam Borthakur, Kiran Naqvi, Sarah Pelletier, Sherry Pierce, Michael Andreeff, Guillermo Garcia-Manero, Jorge E. Cortes, Tapan M. Kadia
CANCER (2021)
High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
Fabiana Cacace, Rossella Iula, Danilo De Novellis, Valeria Caprioli, Maria Rosaria D'Amico, Giuseppina De Simone, Rosanna Cuccurullo, William G. Wierda, Kris Michael Mahadeo, Giuseppe Menna, Francesco Paolo Tambaro
BIOMEDICINES (2022)
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
Roberto Limongello, Andrea Marra, Antonella Mancusi, Samanta Bonato, Eni Hoxha, Loredana Ruggeri, Susanta Hui, Andrea Velardi, Antonio Pierini
FRONTIERS IN IMMUNOLOGY (2021)
Measurable Residual Disease in High-Risk Acute Myeloid Leukemia
Thomas Cluzeau, Roberto M. Lemoli, James McCloskey, Todd Cooper
CANCERS (2022)
TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients
Han Liu, Peng Chen, Yong-Long Yang, Ke-Wei Zhu, Tao Wang, Ling Tang, Yan-Ling Liu, Shan Cao, Gan Zhou, Hui Zeng, Xie-Lan Zhao, Wei Zhang, Xiao-Ping Chen
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Phaedon D. D. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou, Theodoros Karantanos
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)
Muhammed Burak Demircan, Tina M. Schnoeder, Peter C. Mgbecheta, Katrin Schroeder, Frank-D Boehmer, Florian H. Heidel
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Psychological mobile app for patients with acute myeloid leukemia (AML): A pilot randomized clinical trial
Areej El-Jawahri, Marlise R. Luskin, Joseph A. Greer, Lara Traeger, Mitchell Lavoie, Dagny Marie Vaughn, Stephanie Andrews, Daniel Yang, Kofi Y. Boateng, Richard A. Newcomb, Nneka N. Ufere, Amir T. Fathi, Gabriela Hobbs, Andrew Brunner, Gregory A. Abel, Richard M. Stone, Daniel J. DeAngelo, Martha Wadleigh, Jennifer S. Temel
CANCER (2023)
Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival
Ali H. Amin, Liqaa Mohammed Al Sharifi, Alisher Jamoliddinovich Kakhharov, Maria Jade Catalan Opulencia, Fahad Alsaikhan, Dmitry Olegovich Bokov, Hasan Sh Majdi, Mohammed Abed Jawad, Ali Thaeer Hammid, Mohammed Nader Shalaby, Yasser Fakri Mustafa, Homayoon Siahmansouri
BIOMEDICINE & PHARMACOTHERAPY (2022)
Maintenance Therapy in AML
Patrick K. Reville, Tapan M. Kadia
FRONTIERS IN ONCOLOGY (2021)
Integrated N- and O-Glycomics of Acute Myeloid Leukemia (AML) Cell Lines
Constantin Blochl, Di Wang, Katarina Madunic, Guinevere S. M. Lageveen-Kammeijer, Christian G. Huber, Manfred Wuhrer, Tao Zhang
CELLS (2021)
Molecular Characterization of the Highest Risk Adult Patients With Acute Myeloid Leukemia (AML) Through Multi-Omics Clustering
Trinh Nguyen, John W. Pepper, Cu Nguyen, Yu Fan, Ying Hu, Qingrong Chen, Chunhua Yan, Daoud Meerzaman
FRONTIERS IN GENETICS (2021)
Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome
Brian Pham, Rasmus Hoeg, Rajeev Krishnan, Carol Richman, Joseph Tuscano, Mehrdad Abedi
BONE MARROW TRANSPLANTATION (2021)
Adenosine Monophosphate Activated Protein Kinase (AMPK) enhances chemotherapy response in Acute Myeloid Leukemia (AML)
Lais Ghiraldeli, Rebecca Anderson, Kristin Pladna, Timothy S. Pardee
CANCER LETTERS (2022)
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
Mareike Rasche, Martin Zimmermann, Emma Steidel, Todd Alonzo, Richard Aplenc, Jean-Pierre Bourquin, Heidrun Boztug, Todd Cooper, Alan S. Gamis, Robert B. Gerbing, Iveta Janotova, Jan-Henning Klusmann, Thomas Lehrnbecher, Nora Muehlegger, Nils V. Neuhoff, Naghmeh Niktoreh, Lucie Sramkova, Jan Stary, Katharina Waack, Christiane Walter, Ursula Creutzig, Michael Dworzak, Gertjan Kaspers, Edward Anders Kolb, Dirk Reinhardt
CANCERS (2021)
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia
Kendra L. Sweet, Jorge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler, Cristina Ruiz, Charles A. Schiffer, Lori A. Ehrlich, Gulsum E. Pamuk, Joseph Wynne, Gautam U. Mehta, R. Angelo de Claro, Marc R. Theoret, B. Douglas Smith, Kelly J. Norsworthy
CLINICAL CANCER RESEARCH (2023)
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial
Jorge E. Cortes, Andreas Hochhaus, Naoto Takahashi, Richard A. Larson, Ghayas C. Issa, Felice Bombaci, Nicholas Ramscar, Sophie Ifrah, Timothy P. Hughes
FUTURE ONCOLOGY (2023)
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL
Andreas Hochhaus, Delphine Rea, Carla Boquimpani, Yosuke Minami, Jorge E. Cortes, Timothy P. Hughes, Jane F. Apperley, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, Valentin Garcia-Gutierrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Veronique Bedoucha, Michael J. Mauro
LEUKEMIA (2023)
Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
Camilo Montero, Nancy Yomayusa, Rodolfo Torres, Jorge Cortes, Carlos Alvarez, Juan Gallo, Guillermo Aldana, Andres Acevedo, Maria Rios, Johana Echeverri, Zuly Yepes, Adriana Silva, Diana Gayon, Jorge Perez, Milciades Ibanez
NEFROLOGIA (2023)
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results
Michael J. Mauro, Timothy P. Hughes, Dong-Wook Kim, Delphine Rea, Jorge E. Cortes, Andreas Hochhaus, Koji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J. DeAngelo, Michael C. Heinrich, Valle Gomez-Garcia de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J. W. M. Janssen, Michael Deininger, Naranie Shanmuganathan, Mark B. Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
LEUKEMIA (2023)
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia
Fabio Efficace, Francesco Cottone, Betina Yanez, Vamsi Kota, Fausto Castagnetti, Giovanni Caocci, Massimiliano Bonifacio, Andrea Patriarca, Isabella Capodanno, Maria Cristina Miggiano, Mario Tiribelli, Massimo Breccia, Luigia Luciano, Valentina Giai, Alessandra Iurlo, Elisabetta Abruzzese, Carmen Fava, Shira Dinner, Jessica K. Altman, Gianantonio Rosti, Jorge Cortes, Marco Vignetti, David Cella
CANCER (2023)
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End Results
Koji Sasaki, Kiyomi Morita, Hagop Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Marina Konopleva, Gautam Borthakur, William Wierda, Naval Daver, Koichi Takahashi, Courtney Dinardo, Guillermo Montalban Bravo, Ghayas C. Issa, Sherry A. Pierce, Kelly A. Soltysiak, Martha S. Tingen, Jorge E. Cortes
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers
Pankaj Ahluwalia, Ashutosh Vashisht, Harmanpreet Singh, Nikhil Shri Sahajpal, Ashis K. Mondal, Kimya Jones, Jaspreet Farmaha, Ryan Bloomquist, Caroline Marie Carlock, Drew Fransoso, Christina Sun, Tyler Day, Comfort Prah, Trinh Vuong, Patty Ray, Danielle Bradshaw, Marisol Miranda Galvis, Sadanand Fulzele, Girindra Raval, Justin Xavier Moore, Jorge Cortes, Jeffrey N. James, Vamsi Kota, Ravindra Kolhe
JOURNAL OF MEDICAL VIROLOGY (2023)
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia
Mahesh Swaminathan, Jorge E. E. Cortes
THERAPEUTIC ADVANCES IN HEMATOLOGY (2023)
Outcomes with bosutinib vs. imatinib by Charlson Comorbidity Index in patients with chronic myeloid leukaemia
Gemma Shay, Michael W. Deininger, Tim H. Bruemmendorf, Jeffrey H. Lipton, Leif Stenke, Eric Leip, Simon Purcell, Andrea Viqueira, Jorge E. Cortes
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in First Complete Remission (CR1) in Addition to FLT3 Inhibition With Quizartinib in Acute Myeloid Leukemia (AML) With FLT3-Internal Tandem Duplication (FLT3-ITD): Results from the QuANTUM-First Trial
Richard F. Schlenk, Pau Montesinos, Antonio Romero-Aguilar, Radovan Vrhovac, Elzbieta Patkowska, Hee-Je Kim, Pavel Zak, Po-Nan Wang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Arnaud Lesegretain, Jorge Cortes, Mikkael A. Sekeres, Herve Dombret, Sergio Amadori, Jianxiang Wang, Alexander E. Perl, Mark J. Levis, Harry P. Erba
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Define the Vulnerable - Social Determinants of Health Impact on Hematological Malignancies Affecting Children, Adolescents, and Young Adults: Systematic Review and Meta-Analysis
Muhannad Sharara, Kellen Cristine Tjioe, Marisol Miranda Galvis, Gagan Agrawal, Andrew Balas, Jorge Cortes
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients - A Real-World Study
Ana Toreli, Marisol Miranda-Galvis, Marcelo Addas-Carvalho, Eliana Miranda, Leonardo Fechio, Adriana Duarte, Audrey Basso, Gislaine Duarte, Samuel Medina, Fernando Pericole, Bruno Benites, Ravindra Kolhe, Kimya Jones, Harmanpreet Singh, Sara Teresinha Olalla Saad, Carmino Antonio de Souza, Jorge Cortes, Katia Pagnano
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
QuANTUM-First Trial: FLT3-Internal Tandem Duplication (FLT3-ITD)-Specific Measurable Residual Disease (MRD) Clearance Is Associated With Improved Overall Survival (OS)
Mark J. Levis, Harry P. Erba, Pau Montesinos, Radovan Vrhovac, Elzbieta Patkowska, Hee-Je Kim, Pavel Zak, Po-Nan Wang, Jaime E. Connolly Rohrbach, Ken C. N. Chang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Arnaud Lesegretain, Jorge Cortes, Mikkael A. Sekeres, Herve Dombret, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Alexander E. Perl
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Responses With Asciminib Continue to Deepen Over Time in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After ≥2 Prior Tyrosine Kinase Inhibitors (TKIs) in the Phase III ASCEMBL Study
Michael Mauro, Andreas Hochhaus, Timothy Hughes, Delphine Rea, Carla Boquimpani, Yosuke Minami, Jane Apperley, Valentin Garcia-Gutierrez, Shruti Kapoor, Noemi Espurz, Vishal Dhamal, Jorge Cortes
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)